Cancer cells evade immune surveillance through numerous mechanisms, including:
reduced expression of tumor antigens
downregulation of MHC class I and II molecules thus reducing tumor-antigen presentation
immunosuppressive cytokines such as tumor growth factor-β
induction of immunosuppressive cells (regulatory T cells or myeloid-derived suppressor cells [MDSC])
overexpression of immune checkpoint ligands